Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Holding RPRX?
Track your performance easily
Royalty Pharma (RPRX) Ownership Overview
8.05% Insiders
19.64% Mutual Funds
20.44% Other Institutional Investors
12.51% ETFs
39.37% Public Companies and Individual Investors
The ownership structure of Royalty Pharma (RPRX) stock is a mix of institutional, retail, and individual investors. Approximately 52.58% of the company’s stock is owned by Institutional Investors, 8.05% is owned by Insiders, and 39.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 04, 2024 | Rory Riggs Director | xxxxxxxxxxxxx | $13219728 |
| Jan 03, 2024 | Avara Management Ltd >10% Owner | xxxxxxxxxxxxx | $1845116 |
| Dec 29, 2023 | Avara Management Ltd >10% Owner | xxxxxxxxxxxxx | $7086549 |
| Dec 19, 2023 | Avara Management Ltd >10% Owner | xxxxxxxxxxxxx | $286412 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $5164643 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $6302192 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $64002627 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $315650429 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 36,302,364 | Institution | 8.17% | 932,970,755 | |
| 32,555,339 | Insider | 7.33% | 836,672,212 | |
| 32,494,327 | Institution | 7.31% | 835,104,204 | |
| 11,970,058 | Institution | 2.69% | 307,630,491 | |
| 9,019,829 | Institution | 2.03% | 231,809,605 | |
| 4,041,675 | Institution | 0.91% | 103,871,048 | |
| 4,000,994 | Institution | 0.90% | 102,825,546 | |
| 3,392,000 | Institution | 0.76% | 87,174,400 | |
| 3,262,300 | Institution | 0.73% | 83,841,110 | |
| 2,491,699 | Institution | 0.56% | 64,036,664 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 32,494,327 | Institution | 7.31% | 835,104,204 | |
| 4,041,675 | Institution | 0.91% | 103,871,048 | |
| 4,000,994 | Institution | 0.90% | 102,825,546 | |
| 3,392,000 | Institution | 0.76% | 87,174,400 | |
| 3,262,300 | Institution | 0.73% | 83,841,110 | |
| 2,491,699 | Institution | 0.56% | 64,036,664 | |
| 2,483,589 | Institution | 0.56% | 63,828,237 | |
| 2,424,730 | Institution | 0.55% | 62,315,561 | |
| 2,061,249 | Institution | 0.46% | 52,974,099 | |
| 1,962,005 | Institution | 0.44% | 50,423,529 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,012,827 | Institution | 2.70% | 339,842,876 | |
| 8,067,082 | Institution | 1.82% | 228,217,750 | |
| 5,794,552 | Institution | 1.30% | 163,927,876 | |
| 3,227,360 | Institution | 0.73% | 91,302,014 | |
| 2,611,881 | Institution | 0.59% | 73,890,113 | |
| 1,604,584 | Institution | 0.36% | 45,393,681 | |
| 1,277,317 | Institution | 0.29% | 36,135,298 | |
| 1,280,491 | Institution | 0.29% | 32,908,619 | |
| 991,655 | Institution | 0.22% | 25,366,535 | |
| 963,549 | Institution | 0.22% | 24,763,209 |
FAQ
Who Owns Royalty Pharma PLC (RPRX)?
According to the latest TipRanks data, approximately 20.44% of the company's stock is held by institutional investors, 8.05% is held by insiders, and 39.37% is held by retail investors.
What percentage of Royalty Pharma PLC (RPRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.44% of Royalty Pharma PLC (RPRX) stock is held by institutional investors.
What percentage of Royalty Pharma PLC (RPRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.37% of Royalty Pharma PLC (RPRX) stock is held by retail investors.
Who owns the most shares of Royalty Pharma PLC (RPRX)?
Vanguard owns the most shares of Royalty Pharma PLC (RPRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.